BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25999350)

  • 1. Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells.
    Chen C; Zhao M; Tian A; Zhang X; Yao Z; Ma X
    Oncotarget; 2015 Jul; 6(19):17570-83. PubMed ID: 25999350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B; Cheng D; Li S; Zhou S; Yang Q
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.
    Pedersen EA; Menon R; Bailey KM; Thomas DG; Van Noord RA; Tran J; Wang H; Qu PP; Hoering A; Fearon ER; Chugh R; Lawlor ER
    Cancer Res; 2016 Sep; 76(17):5040-53. PubMed ID: 27364557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
    Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
    Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
    J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
    Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
    J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
    Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
    Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.
    Sun J; Yan P; Chen Y; Chen Y; Yang J; Xu G; Mao H; Qiu Y
    Diagn Pathol; 2015 Jun; 10():72. PubMed ID: 26088648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells.
    Zhang RX; Li Y; Tian DD; Liu Y; Nian W; Zou X; Chen QZ; Zhou LY; Deng ZL; He BC
    Int J Oncol; 2016 Nov; 49(5):1973-1982. PubMed ID: 27665868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/β-catenin target gene, CDC25A.
    Vijayakumar S; Liu G; Rus IA; Yao S; Chen Y; Akiri G; Grumolato L; Aaronson SA
    Cancer Cell; 2011 May; 19(5):601-12. PubMed ID: 21575861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant activation of Wnt/β-catenin signaling pathway contributes to the sequential progression of DMBA-induced HBP carcinomas.
    Vidya Priyadarsini R; Senthil Murugan R; Nagini S
    Oral Oncol; 2012 Jan; 48(1):33-9. PubMed ID: 21924667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
    Liu Y; Liu YZ; Zhang RX; Wang X; Meng ZJ; Huang J; Wu K; Luo JY; Zuo GW; Chen L; Yin LJ; Deng ZL; He BC
    Int J Oncol; 2014 Aug; 45(2):795-803. PubMed ID: 24859848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
    Zhang KS; Zhou Q; Wang YF; Liang LJ
    Oncol Rep; 2013 Sep; 30(3):1430-8. PubMed ID: 23799613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.
    Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Otterson MF; Behmaram B; Gockel I; Mackinnon A; Shaker R
    Neoplasia; 2015 Jul; 17(7):598-611. PubMed ID: 26297437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
    Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
    Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma.
    Sarkar S; Mandal C; Sangwan R; Mandal C
    Endocr Relat Cancer; 2014 Feb; 21(1):113-25. PubMed ID: 24402132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.